QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

COR

QT67Cencora, Inc.
NYSE·Healthcare·Medical - Distribution·USA
Latest market price
271.83
-5.26-1.90%
OverviewShort InterestFilings
CORQT67Cencora, Inc.·NYSE
OverviewShort InterestFilings
271.83-1.90%
TA
Loading chart...
Screen all →
MCK-3.74%$750.63CAH-1.99%$221.77HSIC-0.06%$79.92GRDN-2.28%$42.41PBH+1.80%$46.97
Snapshot
Index-P/E21.15EPS (ttm)13.04Insider Own16.18%Shs Outstand194.56M
Perf Week-3.43%
Market Cap53.91BForward P/E13.72EPS next Y19.81Insider Trans0.04%Shs Float-Perf Month2.13%
Enterprise Value64.06BPEG0.41EPS next Q4.37Inst Own-Short Float-Perf Quarter-18.06%
Income2.55BP/S0.16EPS this Y36.32%Inst Trans-Short Ratio-Perf Half Y-20.45%
Sales328.68BP/B15.87EPS next Y11.42%ROA3.12%Short Interest-Perf YTD-19.52%
Book/sh18.43P/C23.68EPS next 5Y14.95%ROE115.93%52W High377.54 -28.00%Perf Year-7.29%
Cash/sh11.49P/FCF34.60EPS past 3/5Y-ROIC11.89%52W Low244.83 11.03%Perf 3Y-
Dividend Est.2.35 (0.86%)EV/EBITDA12.82Sales past 3/5Y10.43% 11.09%Gross Margin3.47%Volatility1.79% 1.70%Perf 5Y-
Dividend TTM2.35 (0.86%)EV/Sales0.19EPS Y/Y TTM121.38%Oper. Margin1.28%ATR (14)6.91Perf 10Y-
Dividend Ex-DateMay 15, 2026Quick Ratio0.59Sales Y/Y TTM11.81%Profit Margin0.78%RSI (14)43.40Recom2.00
Dividend Gr. 3/5Y6.46% 5.77%Current Ratio0.95EPS Q/Q7.47%SMA20-0.49%Beta-0.03Target Price378.57
Payout18.01%Debt/Eq3.65Sales Q/Q3.85%SMA50-4.88%Rel Volume1.85Prev Close277.09
Employees47,000LT Debt/Eq5.94EarningsAug 05SMA200-16.32%Avg Volume1.82MPrice271.83
IPO DateApr 04, 1995Option/ShortYes / YesEPS/Sales Surpr.-1.45% -3.37%Net Debt/EBITDA2.03Volume3,365,487Change-1.90%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-10-26ReiteratedBarclaysOverweight$425 → $350
May-11-26ReiteratedWells FargoOverweight$429 → $331
May-08-26ReiteratedMorgan StanleyOverweight$400 → $342
May-07-26ReiteratedUBSBuy$415 → $412
Apr-08-26ReiteratedEvercore ISI$420 → $360
Mar-17-26ReiteratedMorgan StanleyOverweight$400 → $380
Feb-13-26ReiteratedBarclaysOverweight$400 → $425
Feb-10-26ReiteratedWells FargoOverweight$354 → $429
Feb-05-26ReiteratedEvercore ISI$440 → $420
Jan-29-26UpgradeMorgan StanleyEqual Weight → Overweight$330 → $400
Latest News
Jun-18-26
Jun-18-2604:49PM
COR Stock Down Nearly 18% YTD: Should You Buy, Hold or Sell?Yahoo
02:33PM
Cencora Launches Enhanced Nucleus Solution for Specialty PracticesYahoo
12:00PM
Bet on 5 Top-Ranked Stocks With Rising P/E for Solid ReturnsYahoo
Jun-17-26
Jun-17-2612:55PM
Add These 4 GARP Stocks to Your Portfolio to Receive Handsome ReturnsYahoo
12:00PM
Cencora Launches Next-Generation Nucleus® Solution with Multi-Site Pilot Across Specialty Physician PracticesYahoo
Jun-15-26
Jun-15-2608:15PM
Cencora Announces Samantha Hammock as Chief Human Resources OfficerYahoo
03:47PM
Cardinal Health Stock: Is CAH Outperforming the Healthcare Sector?Yahoo
Jun-10-26
Jun-10-2604:13PM
Assessing Cencora (COR) Valuation After Kite CAR T Distribution Deal And Upcoming CFO TransitionYahoo
04:13PM
Assessing Cencora (COR) Valuation After Kite CAR T Distribution Deal And Upcoming CFO TransitionYahoo
02:05PM
Cencora Kite Deal Highlights CAR T Growth And Undervalued Share Price PotentialYahoo
02:05PM
Cencora Kite Deal Highlights CAR T Growth And Undervalued Share Price PotentialYahoo
10:27AM
Barclays Maintains Overweight on Cencora, Lowers Price Target to $350Benzinga
10:27AM
Barclays Maintains Overweight on Cencora, Lowers Price Target to $350Benzinga
Jun-09-26
Jun-09-2603:05PM
2 Dirt Cheap Healthcare Stocks to Buy With $1,000 Right NowYahoo
03:05PM
2 Dirt Cheap Healthcare Stocks to Buy With $1,000 Right NowYahoo
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
9/30/2025
FY 2024
9/30/2024
FY 2023
9/30/2023
FY 2022
9/30/2022
FY 2021
9/30/2021
FY 2020
9/30/2020
FY 2019
9/30/2019
FY 2018
9/30/2018
Total Revenue328,681321,333293,959
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A317,283311,191285,257
Gross Profit11,39610,1428,701
Selling, General and Administrative Excl. Other7,1956,4945,661
Research and Development
000
Other Operating Expense
000
Operating Income4,2023,6483,040
Interest Expense473420249
Unusual Expense
———
Non-Operating Income (Expense)241970787
Net Income Before Taxes3,5072,2582,004
Income Taxes955691485
Consolidated Net Income2,5481,5541,509
Net Income From Continuing Operations2,5531,5681,519
Net Income2,5481,5541,509
EPS (Recurring)13.128.027.60
EPS (Basic, Before Extraordinaries)13.128.027.60
EPS (Diluted)13.047.967.53
EBITDA4,9953,7363,364
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio20.8539.26—
Price To Sales Ratio0.160.19—
Gross Margin3.473.162.96
Operating Margin1.281.141.03
Net Margin0.780.480.51
Shares Outstanding195194199
Market Capitalization53,00760,631—
Operating Lease Expense
———
Insider Trading Volume
$286.72$255.31$223.90$192.49$161.08● Close Price0.00M2.64M5.28M7.92M10.57MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
DURCAN DERMOT MARKDirectorMay 28 '26Buy266.264,0001,065,04027,767May 28 12:00 AM
Battaglia SilvanaExecutive Vice PresidentMar 11 '26Option Exercise0.0016,830027,239Mar 13 12:00 AM
Campbell Elizabeth SExecutive Vice PresidentMar 11 '26Option Exercise0.0025,246036,548Mar 13 12:00 AM
Cleary James FChief Financial OfficerMar 11 '26Option Exercise0.0025,2460165,766Mar 13 12:00 AM
Mauch Robert P.President & CEOFeb 20 '26Sale358.943,7621,350,33265,393Feb 24 12:00 AM
Mauch Robert P.President & CEOFeb 20 '26Option Exercise86.097,524647,74269,155Feb 24 12:00 AM
Mauch Robert P.President & CEOFeb 18 '26Sale359.461,333479,16065,393Feb 20 12:00 AM
Mauch Robert P.President & CEOJan 20 '26Option Exercise86.097,526647,91471,822Jan 22 12:00 AM
Mauch Robert P.President & CEOJan 20 '26Sale354.735,0961,807,70466,726Jan 22 12:00 AM
Campbell Elizabeth SExecutive Vice PresidentDec 19 '25Sale342.103,3511,146,37723,891Dec 22 12:00 AM
Battaglia SilvanaExecutive Vice PresidentDec 19 '25Sale345.001,677578,56518,796Dec 22 12:00 AM
Mauch Robert P.President & CEODec 18 '25Option Exercise86.097,526647,91473,155Dec 22 12:00 AM
Mauch Robert P.President & CEODec 18 '25Sale343.455,0961,750,22168,059Dec 22 12:00 AM
Krikorian LazarusSVP & Chief Accounting OfficerDec 17 '25Sale343.244,0311,383,58017,154Dec 19 12:00 AM
Cleary James FChief Financial OfficerDec 17 '25Option Exercise86.0990,3087,774,616180,095Dec 19 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR